Showing 2671-2680 of 3494 results for "".
Hidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.Considering Going Direct Pay?
https://practicaldermatology.com/topics/practice-management/considering-going-direct-pay/23552/A dermatologist shares thoughts on what “direct care” really means.A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.At-home Medical Aesthetic Devices: What Your Patients Should Be Aware Of
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/at-home-medical-aesthetic-devices-what-your-patients-should-be-aware-of/23149/Despite some reputable standouts, most consumer-grade medical aesthetic devices are manufactured overseas and sold online and tend to be of somewhat suspect quality.Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.The State of Pediatric Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-pediatric-dermatology/23060/The subspecialty needs to expand its workforce to continue to meet critical patient need.Prospective Analysis: PRP Post-Mohs; Physician Debt Insights
https://practicaldermatology.com/youngmd-connect/resident-resource-center/propsective-analysis-prp-post-mohs-physician-debt-insights/23038/Approval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healThe Future Is Now: Technology for Skincare
https://practicaldermatology.com/topics/practice-management/the-future-is-now-technology-for-skincare/20814/AI and AR are changing the way skin care is prescribed.A Novel Therapeutic Option for the Treatment of Molluscum Contagiosum
https://practicaldermatology.com/topics/general-topics/a-novel-therapeutic-option-for-the-treatment-of-molluscum-contagiosum/21040/There is no FDA approved treatment for molluscum. A novel intervention may erradicate Molluscum with one treatment.